New Software Based on Assumptions in CDC FluSurge Program
Contact: Alyssa Zeff
BD Public Relations
Franklin Lakes, N.J. (February 07, 2007) --
BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch of BD FluStockSM, a planning service designed to help hospitals identify critical BD medical devices and estimate appropriate inventory levels in order to better prepare for pandemic influenza.
BD FluStock utilizes a new proprietary software tool created by BD and addresses two related considerations for supply planning:
BD FluStock will generate customized planning recommendations for healthcare continuity and patient surge considerations, as well as overall planning reports.These reports will include inventory volume recommendations based on user-selected criteria for pandemic influenza.
“In our conversations with customers, we learned that hospitals are feeling overwhelmed by everything that needs to be done to prepare for a possible influenza pandemic,” said George Goldman, Senior Director, Hypodermic, BD Medical - Medical Surgical Systems. “We developed BD FluStock to give hospitals a tangible pandemic preparedness tool they can use right away.”
BD FluStock is one of several tools in the “BD. Delivering Preparedness” kits developed to aid hospitals and public health agencies with their pandemic preparedness efforts.These tools include reference materials, injection training kits and a dedicated pandemic hotline.Additionally, BD is offering special pricing for public health agencies.
BD FluStock was created using key assumptions from CDC's FluSurge Program, created by Drs. Zhang, Meltzer and Wortley, U.S. Centers for Disease Control and Prevention - CDC.FluSurge is a spreadsheet-based model which provides hospital administrators and public health officials estimates of the surge in demand for hospital-based services during the next pandemic influenza. FluSurge estimates the number of hospitalizations and deaths of a pandemic influenza (whose length and virulence are determined by the user) and compares the number of persons hospitalized, the number of persons requiring ICU care, and the number of persons requiring ventilator support during a pandemic with existing hospital capacity. For more information about FluSurge and other CDC pandemic planning tools, please visit http://www.pandemicflu.gov/plan/tools.html.*
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 27,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.
* Citation of research and products completed by employees of the U.S. Dept. of Health and Human Services and CDC does not constitute endorsement of any products or services.